Clinical Trials on Moderate to Heavy Smokers
Total 419 results
-
AstraZenecaCompletedHealthy Elderly Volunteers | Mild-to-moderate Alzheimer's Disease PatientsUnited States
-
Hospices Civils de LyonCompletedModerate to Severe Hearing Loss | Indication of Middle Ear Implant (MET)
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Denmark, France, Sweden, Thailand, Vietnam, Belgium, Brazil, Peru, Philippines, Turkey, Taiwan, Argentina, Australia, Israel, Poland, Ukraine, Slovenia, Serbia, Mexico, Bulgaria, Colombia, New Zealand, Chile, Norway, Croatia
-
AstraZenecaMedImmune LLCCompletedModerate to Very Severe Chronic Obstructive Pulmonary DiseaseUnited States, Canada, Germany, Italy, Netherlands, Spain, United Kingdom, Poland, Japan, Austria, Korea, Republic of, Russian Federation, South Africa, Czechia, Hungary, Romania, Switzerland
-
Merz Therapeutics GmbHRecruitingModerate to Severe Chronic Peripheral Neuropathic Pain (PNP) Due to Postherpetic Neuralgia (PHN) or Peripheral Nerve InjuryBulgaria, Germany, Poland, France, Hungary, Spain
-
Government Medical College, BhavnagarCompletedModerate to Severe Persistent Bronchial AsthmaIndia
-
Suzhou Connect Biopharmaceuticals, Ltd.CompletedModerate to Severe Persistent AsthmaUnited States, China, Hungary, Korea, Republic of, Poland
-
Two Pi Signalprocessing Applications GmbHCompletedMild to Moderate Sensorineural Hearing LossNetherlands
-
Meir Medical CenterUnknownHealthy Subjects | Moderate to Severe Keratoconjunctivitis Sicca (KCS) | Dry Eye Syndrome (DES)
-
Sunnaas Rehabilitation HospitalUniversity of BergenCompletedHemiplegia | Cerebral Stroke | Moderate to Severe Functional ImpairmentsNorway
-
Jiangsu HengRui Medicine Co., Ltd.Active, not recruitingModerate to Severe Acute PainChina
-
Bruyere Research InstituteUniversity of OttawaCompletedMild Cognitive Impairment | Alzheimer's Disease | Mild to Moderate DementiaCanada
-
AbbVieTerminated
-
Helius Medical IncRecruitingGait Impairment Due to Mild/Moderate Multiple Sclerosis (MS)United States
-
University of North Carolina, Chapel HillMed-El CorporationCompletedUnilateral Moderate to Profound Hearing Loss | Asymmetric Hearing Loss | Single-Sided Deafness (SSD)United States
-
Pirogov Russian National Research Medical UniversityCity Clinical Hospital No.52 of Moscow Healthcare DepartmentCompletedCOVID-19 | Mild to ModerateRussian Federation
-
Westlake Pharmaceuticals (Hangzhou) Co., Ltd.RecruitingMild to Moderate COVID-19China
-
SanofiRegeneron PharmaceuticalsRecruitingModerate to Severe Atopic DermatitisCanada
-
MEDA PHARMA SPA, a Viatris companyNot yet recruitingMild to Moderate Atopic Dermatitis
-
Beijing InnoCare Pharma Tech Co., Ltd.RecruitingModerate to Severe Atopic DermatitisChina
-
Keymed Biosciences Co.LtdRecruitingModerate-to-severe Atopic DermatitisChina
-
Galderma R&DRecruitingModerate-to-Severe Atopic DermatitisUnited States, Denmark, Hungary, Poland, Spain
-
Shanghai Hengrui Pharmaceutical Co., Ltd.CompletedModerate to Severe Atopic DermatitisChina
-
UCB Biopharma SRLCompletedPsoriatic Arthritis | Moderate to Severe Chronic Plaque Psoriasis | Chronic Plaque PsoriasisUnited States, Australia, Belgium, Canada, Germany, Hungary, Italy, Japan, Poland, Russian Federation, United Kingdom
-
Galderma R&DActive, not recruitingModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Belgium, Bulgaria, Canada, Czechia, Estonia, France, Georgia, Germany, Hungary, Italy, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Singapore, Spain, United Kingdom
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Belgium, Bulgaria, Estonia, France, Georgia, Germany, Hungary, Italy, Poland, Singapore
-
Galderma R&DCompletedModerate-to-Severe Atopic DermatitisUnited States, Australia, Austria, Canada, Czechia, Germany, Korea, Republic of, Latvia, Lithuania, Netherlands, New Zealand, Poland, Spain, United Kingdom
-
Ology BioservicesPharm-Olam, LLC; Chemical, Biological, Radiological, and Nuclear MedicalWithdrawnMild to Moderate COVID-19
-
Kaleido BiosciencesCompletedMild-to-Moderate COVID-19United States
-
Kaleido BiosciencesCompletedMild-to-moderate COVID-19United States
-
Keymed Biosciences Co.LtdCompletedModerate-to-severe Atopic DermatitisChina
-
University of Texas Southwestern Medical CenterChildren's Medical Center DallasTerminatedModerate to Severe Atopic DermatitisUnited States
-
Hospices Civils de LyonCompletedModerate to Severe Traumatic Brain InjuryFrance
-
Duke UniversityAlzheimer's Association; Duke-NUS Graduate Medical School; Duke Institute for...CompletedMild Cognitive Impairment | Mild to Moderate Cognitive ImpairmentUnited States
-
Creabilis SATerminated
-
Technische Universität DresdenCompletedModerate to Severe Atopic DermatitisGermany
-
Jiangsu vcare pharmaceutical technology co., LTDRecruitingModerate to Severe Atopic DermatitisChina
-
Oneness Biotech Co., Ltd.RecruitingMild to Moderate COVID-19Taiwan, United States
-
HK inno.N CorporationNot yet recruiting
-
Keymed Biosciences Co.LtdRecruitingModerate-to-severe Atopic DermatitisChina
-
Shanghai Hengrui Pharmaceutical Co., Ltd.Not yet recruiting
-
Keymed Biosciences Co.LtdRecruiting
-
Technische Universität DresdenRecruitingModerate-to-severe Atopic DermatitisGermany
-
Inmagene LLCActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic Dermatitis | ADCanada, United States
-
AmgenActive, not recruitingAtopic Dermatitis | Moderate-to-severe Atopic DermatitisUnited States, Canada
-
Galderma R&DWithdrawn
-
Regeneron PharmaceuticalsSanofiCompletedModerate-to-severe Atopic DermatitisUnited States
-
Shanghai Vinnerna Biosciences Co., Ltd.Sponsor GmbHCompleted
-
Guangdong Raynovent Biotech Co., LtdCompletedMild to Moderate COVID-19China
-
Keymed Biosciences Co.LtdCompletedModerate-to-severe Atopic DermatitisChina